Although autograft is still perceived as the
gold-standard material in bone grafting, the wide array of alternatives
available in the market has resulted in a gradual shift towards increased
adoption of bone grafts and substitutes (BGS), especially in the US and
European markets. In contrast to the general picture in developed countries,
autograft bone still represents the most popular option during bone grafting in
the Asia-Pacific (APAC) region and South America.
The global competitive landscape in each of the
segments (including traditional allograft bone, machined allograft bone, BMPs,
DBMs, synthetic bone substitutes, and cell-based matrices) is difficult to
define as the regulatory conditions for BGS differ from country to country, and
therefore the market leaders can vary significantly in each segment of the
market.
Scope
- An overview of BGS, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized APAC BGS market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.
- Investigation of current and future market competition for BGS.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the BGS sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL).
Reasons to buy
- Understand the trends shaping and driving APAC BGS Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in APAC BGS market through 2019.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in APAC BGS market landscape? Identify, understand and capitalize.
Spanning
over 183 pages, 93 Tables And 18 Figures “Bone
Grafts and Substitutes - APAC Analysis and Market Forecasts” report provide
Clinical Outcomes, Industry Overview, Competitive Assessment, Unmet Needs,
Pipeline Products, Clinical Trials to Watch, Current and Future Players, Market
Outlooks, Appendix. The Report Cover 16 Companies - Alphatec Spine, AlloSource,
Bacterin, Biomet, DePuy Synthes, Exactech, Globus Medical, Integra
LifeSciences, Medtronic, NuVasive, Olympus Biotech, Orthofix, RTI Surgical,
Stryker, Wright Medical, Zimmer Holdings.
Inquiry for more information
visit:
For regular industry
updates subscribe to our newsletter at:
No comments:
Post a Comment
Note: only a member of this blog may post a comment.